FDA Advocacy
As the United States nears the peak of the COVID-19 pandemic, it is natural to hope for treatments that can save lives. But when experimental drugs are promoted by a president who has consistently eschewed and misrepresented science, consumers and patients have to exercise caution.
We’re calling on the FDA to let pregnant people receive the abortion pill through the mail so that they can get the pill where they take the pill — at home!
U.S. Food & Drug Administration Public Meeting on Testing Methods for Asbestos in Talc and Cosmetic Products Containing Talc
FOR IMMEDIATE RELEASE Contact: Evita Almassi, ealmassi@nwhn.org
Testimony Delivered at the Meeting of the FDA Bone, Reproductive and Urologic Drugs Advisory Committee
[FDA-2019-N-4203] To Whom It May Concern: The National Women’s Health Network (NWHN) is a nonprofit advocacy organization that works to improve the health of all women. We are supported by our members and by choice, we do not accept financial…
The National Women’s Health Network (The NWHN) believes that more needs to be done to protect people against unnecessary harm caused by silicone gel-filled breast implants. Implants have been on the market for more than 30 years, and during that time they’ve been used by millions of people.
Bremelanotide (brand name: Vyleesi) is a drug approved by the FDA to treat a lack of sexual desire (hypoactive sexual desire disorder) in premenopausal women.
FOR IMMEDIATE RELEASE Contact: Evita Almassi, ealmassi@nwhn.org or 425-749-1886
The NWHN and 42 organizations sent a letter today to the House Energy and Commerce Committee applauding their work on a bipartisan discussion draft to address cosmetics safety.